ES2146657T3 - Sistema de transporte transdermico molecular. - Google Patents

Sistema de transporte transdermico molecular.

Info

Publication number
ES2146657T3
ES2146657T3 ES94923196T ES94923196T ES2146657T3 ES 2146657 T3 ES2146657 T3 ES 2146657T3 ES 94923196 T ES94923196 T ES 94923196T ES 94923196 T ES94923196 T ES 94923196T ES 2146657 T3 ES2146657 T3 ES 2146657T3
Authority
ES
Spain
Prior art keywords
active ingredient
transdermic
molecular
transportation system
blood supply
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94923196T
Other languages
English (en)
Inventor
John J Masiz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/227,365 external-priority patent/US5460821A/en
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of ES2146657T3 publication Critical patent/ES2146657T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Flow Control (AREA)
  • Jet Pumps And Other Pumps (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

UN SISTEMA DE ENVIO TRANSDERMICO EFICAZ PARA SUMINISTRAR UN INGREDIENTE ACTIVO AL SUMINISTRO SANGUINEO DE UN CUERPO VIVIENTE, QUE CONSTA DE UN CONTRAIRRITANTE TOPICO Y/O VASODILATADOR, UN INGREDIENTE ACTIVO, UN REFORZADOR DE PERMEABILIDAD PARA EL INGREDIENTE ACTIVO, Y UNA GOMA SOLUBLE EN AGUA PARA AGLOMERAR LOS ANTERIORES. UNA CAPA NO TRANSPIRANTE PUEDE SER TAMBIEN UTILIZADA PARA CONTROLAR EL MICROAMBIENTE EN LA LOCALIZACION DE TRANSPORTE. SE PUEDE UTILIZAR COMPRESION PARA REFORZAR MAS AUN EL SUMINISTRO SANGUINEO EN LA LOCALIZACION DE TRANSPORTE.
ES94923196T 1993-06-23 1994-06-22 Sistema de transporte transdermico molecular. Expired - Lifetime ES2146657T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8156793A 1993-06-23 1993-06-23
US08/227,365 US5460821A (en) 1993-06-23 1994-04-13 Molecular transdermal transport system

Publications (1)

Publication Number Publication Date
ES2146657T3 true ES2146657T3 (es) 2000-08-16

Family

ID=22164977

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94923196T Expired - Lifetime ES2146657T3 (es) 1993-06-23 1994-06-22 Sistema de transporte transdermico molecular.

Country Status (12)

Country Link
EP (1) EP0705085B1 (es)
JP (1) JPH09501414A (es)
AT (1) ATE190828T1 (es)
AU (1) AU7313694A (es)
BR (1) BR9406900A (es)
CA (1) CA2164109C (es)
DE (1) DE69423616T2 (es)
DK (1) DK0705085T3 (es)
ES (1) ES2146657T3 (es)
GR (1) GR3033445T3 (es)
PT (1) PT705085E (es)
WO (1) WO1995000088A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPM811094A0 (en) * 1994-09-13 1994-10-06 Totalizator Agency Board A combined totalizer and fixed odds betting system and method
JPH11292787A (ja) * 1995-08-15 1999-10-26 Asahi Chem Ind Co Ltd 生理活性ペプチドを含有する経粘膜投与製剤
DE19923427A1 (de) * 1999-05-21 2000-11-23 Lohmann Therapie Syst Lts Vorrichtung und Verfahren zur Steigerung der transdermalen Permeation von Arzneistoffen
DE102005029386A1 (de) * 2005-06-23 2007-01-11 Beiersdorf Ag Wirkstoffkombinationen aus Glycopyrroniumbromid und einem oder mehreren Hydrokolloiden
AU2019349935B2 (en) 2018-09-27 2023-01-12 BioPhysics Pharma, Inc. Transdermal drug delivery system

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3029661A (en) * 1959-07-09 1962-04-17 Falk Corp All purpose speed reducer
US4933184A (en) * 1983-12-22 1990-06-12 American Home Products Corp. (Del) Menthol enhancement of transdermal drug delivery
US4788061A (en) * 1985-07-05 1988-11-29 Shore Ronald N Extended occlusive treatment of skin disorders
IL86170A (en) * 1987-05-01 1992-12-01 Elan Transdermal Ltd Preparations and compositions comprising nicotine for percutaneous administration
US5028431A (en) * 1987-10-29 1991-07-02 Hercon Laboratories Corporation Article for the delivery to animal tissue of a pharmacologically active agent
US4910020A (en) * 1988-10-21 1990-03-20 Macrochem Corporation Transdermal medicator
IE82916B1 (en) * 1990-11-02 2003-06-11 Elan Corp Plc Formulations and their use in the treatment of neurological diseases
US5229130A (en) * 1991-12-20 1993-07-20 Cygnus Therapeutics Systems Vegetable oil-based skin permeation enhancer compositions, and associated methods and systems

Also Published As

Publication number Publication date
JPH09501414A (ja) 1997-02-10
AU7313694A (en) 1995-01-17
CA2164109C (en) 2005-09-27
DE69423616T2 (de) 2000-11-09
CA2164109A1 (en) 1995-01-05
WO1995000088A1 (en) 1995-01-05
DE69423616D1 (de) 2000-04-27
DK0705085T3 (da) 2000-07-24
EP0705085A4 (en) 1997-06-04
PT705085E (pt) 2000-09-29
EP0705085B1 (en) 2000-03-22
BR9406900A (pt) 1996-04-09
ATE190828T1 (de) 2000-04-15
EP0705085A1 (en) 1996-04-10
GR3033445T3 (en) 2000-09-29

Similar Documents

Publication Publication Date Title
DE69520492D1 (de) Flüssige arzneizubereitungen enthaltend schilddrüsenhormone
PT973497E (pt) Dispositivo transportador farmaceutico adequado para administracao de compostos farmaceuticos a superficies mucosas
ES2125380T3 (es) Dispositivo medico para la administracion de ingredientes activos o medicamentos a dosis muy bajas, en especial medicamentos homeopaticos.
TW252919B (es)
TR199801180T2 (xx) Aneljestik etkiye sahip yeni bile�ikler.
DE69637061D1 (de) Neue formulierungen zur transdermalen verabreichung von pergolid
DE122012000020I1 (de) Hautpenetrationsforderer sowie diese verwendende arzneiverabreichungssysteme.
CA2416383A1 (en) Solution-, dispersion- or emulsion-producing film dermatics
DE69721481D1 (de) Wirkstoffformulierungen mit verzögerter freisetzung
DE59808186D1 (de) Transdermales therapeutisches system zur abgabe von hormonen
ID24818A (id) Komposisi farmasi yang digunakan pada selaput lendir
NZ506678A (en) Inorganic nitrite and organic acid in combination as topical antiviral composition
RS49599B (sr) Upotreba inhibitora h+, k+-atp-aze i glukokortikoida i farmaceutska formulacija
WO1999026589A3 (en) Composition for the treatment of burns, sunburns, abrasions, ulcers and cutaneous irritation
DE59510883D1 (de) Scopolaminpflaster
WO2003066130A3 (en) Transdermal drug delivery systems
ES2146657T3 (es) Sistema de transporte transdermico molecular.
TR199801184T2 (xx) Analjezik tesirli yeni bile�ikler.
DE69918124D1 (de) Formulierungen zur transdermalen verabreichung von fenoldopam
WO2002011784A3 (en) Pharmaceutical carriers and compositions for transdermal drug delivery
RU96102110A (ru) Способ профилактики и лечения изъязвлений роговицы
ZA977895B (en) Transdermal therapeutic system having an active compound combination comprising oestriol.
HUP9801869A2 (hu) Készítmény az L-karnitinszint megnövelésére emberben
HUP9800235A2 (hu) Eljárás bőrfertőzések kezelésére és megelőzésére alkalmas külsőleges gyógyászati készítmények előállítására

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 705085

Country of ref document: ES